Sorin
Solo Smart Stentless Aortic Valve Implanted for
First Time in U.S.
Having received FDA approval earlier this year, the
Sorin Group*just an**unced the
First implantation of its
Solo Smart Stentless Aortic heart
Valve in the
U.S. The fully biologic implant*contains ** synthetic materials and is delivered using a stent to provide support during implantation. Once the replacement
Valve is sutured to the
Aortic root, the stent is *******.
Since there’s ** rigid frame as with other valves, which can influence blood flow, the device performs similar to native healthy valves.
Sorin touts the improved visibility of the
Valve during suturing, helping to speed up the procedure
Time and keeping the learning curve similar to stented valves.
“I am excited to have the
Sorin Solo Smart Stentless Valve available to my patients,” said David Heimansohn, M.D., St. Vincent Heart Center, Indianapolis, Indiana. “Solo
Smart is a step forward in the treatment of
Aortic Valve disease, as this surgical
Valve has superior hemodynamic performance, and is much easier to implant, requiring only a single suture line. It more resembles a native
Aortic Valve in appearance and performance, offering the best hemodynamics during all conditions, and improving patients’ lives dramatically”, added Dr. Heimansohn.
Flashback:
Sorin Gets CE Mark for Solo Smart Biological Heart Valve…
Press release:
SORIN GROUP AN**UNCES THE FIRST IMPLANT OF SOLO SMART IN THE UNITED STATES…
